IM+ Capitals Limited
IM+ Capitals Limited Fundamental Analysis
IM+ Capitals Limited (IMCAP.BO) shows moderate financial fundamentals with a PE ratio of 9.67, profit margin of 16.38%, and ROE of 28.82%. The company generates $2.0B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of -139.1/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze IMCAP.BO's fundamental strength across five key dimensions:
Efficiency Score
ExcellentIMCAP.BO demonstrates superior asset utilization.
Valuation Score
ExcellentIMCAP.BO trades at attractive valuation levels.
Growth Score
ModerateIMCAP.BO shows steady but slowing expansion.
Financial Health Score
ExcellentIMCAP.BO maintains a strong and stable balance sheet.
Profitability Score
ModerateIMCAP.BO maintains healthy but balanced margins.
Key Financial Metrics
Is IMCAP.BO Expensive or Cheap?
P/E Ratio
IMCAP.BO trades at 9.67 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, IMCAP.BO's PEG of 0.10 indicates potential undervaluation.
Price to Book
The market values IM+ Capitals Limited at 2.19 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 2.75 times EBITDA. This is generally considered low.
How Well Does IMCAP.BO Make Money?
Net Profit Margin
For every $100 in sales, IM+ Capitals Limited keeps $16.38 as profit after all expenses.
Operating Margin
Core operations generate 16.40 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $28.82 in profit for every $100 of shareholder equity.
ROA
IM+ Capitals Limited generates $18.79 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
IM+ Capitals Limited generates limited operating cash flow of $-373.31M, signaling weaker underlying cash strength.
Free Cash Flow
IM+ Capitals Limited generates weak or negative free cash flow of $-401.88M, restricting financial flexibility.
FCF Per Share
Each share generates $-114.77 in free cash annually.
FCF Yield
IMCAP.BO converts -35.49% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
9.67
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.10
vs 25 benchmark
P/B Ratio
Price to book value ratio
2.19
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.56
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.14
vs 25 benchmark
Current Ratio
Current assets to current liabilities
4.37
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.29
vs 25 benchmark
ROA
Return on assets percentage
0.19
vs 25 benchmark
ROCE
Return on capital employed
0.22
vs 25 benchmark
How IMCAP.BO Stacks Against Its Sector Peers
| Metric | IMCAP.BO Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 9.67 | 19.09 | Better (Cheaper) |
| ROE | 28.82% | 843.00% | Weak |
| Net Margin | 16.38% | 3730.00% | Weak |
| Debt/Equity | 0.14 | 0.90 | Strong (Low Leverage) |
| Current Ratio | 4.37 | 661.68 | Strong Liquidity |
| ROA | 18.79% | -21651.00% (disorted) | Strong |
IMCAP.BO outperforms its industry in 4 out of 6 key metrics, particularly excelling in ROA, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews IM+ Capitals Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Value, Dividend, Cyclical
EPS CAGR
N/A
Industry Style: Value, Dividend, Cyclical
FCF CAGR
N/A
Industry Style: Value, Dividend, Cyclical